Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease.

@article{Palen2006CostEO,
  title={Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease.},
  author={J. G. P. van der Palen and Evelyne Monninkhof and Paul D. L. P. M. van der Valk and Sean D. Sullivan and David L. Veenstra},
  journal={Thorax},
  year={2006},
  volume={61 1},
  pages={29-33}
}
BACKGROUND The evidence for the effectiveness and safety of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) is inconclusive. This study determined the cost effectiveness of withdrawing fluticasone propionate (FP) in outpatients with COPD. METHODS The cost effectiveness analysis was based on a randomised, placebo controlled FP… CONTINUE READING